- CoreWeave reported Q2 2026 EPS of -$1.14 versus a -$1.52 consensus, with revenue of $2.58 billion, up 112.5% year over year.
- CoreWeave raised FY26 revenue guidance to $12.4 billion–$13.2 billion and lifted its year-end annualized run-rate target to $18.5 billion–$19.5 billion.
- Near-term capacity is effectively sold out, and new contracts carry 5–10 percentage points higher contribution margins.
- Q2 net loss widened to $626 million, while the company secured approximately $18 billion in financing to support expansion.
- Managed inference booked ARR rose from $1 million to over $100 million in a few months, with a target of at least $250 million by year-end.
- Bank of America kept its Buy rating on CoreWeave after a roughly 18% drop over two sessions and raised its revenue forecasts.
- The SEC document dated in its title to 2025 covers CoreWeave's Q2 2025 results, including $1.21 billion of revenue; it is prior-year context, not the Q2 2026 event.
Quotes
“CoreWeave saw strong demand and pricing, with near-term capacity effectively sold out”